首页 > 最新文献

Journal of Liver Transplantation最新文献

英文 中文
A revealing scandal: The German transplant scandal between structural failures, moralizing rules, and ambivalent manipulations 揭露性丑闻:结构性失败、道德规范和矛盾操纵之间的德国移植丑闻
Pub Date : 2023-08-01 DOI: 10.1016/j.liver.2023.100168
Julia Rehsmann

Introduction

In 2012, the German transplant scandal was uncovered and reported in the national and international media. This article offers an anthropological analysis of the scandal and examines its ‘scandalous’ characteristics by taking a close look at its extraordinary and ordinary features.

Methods

The article is based on ethnographic research using multiple methods including participant observation, interviewing as well as media and document analysis.

Results

The transplant scandal in Germany revealed systemic ‘scandalous’ features of the national transplant system. From a significant lack of transparency in decision making, a weak legal framework for accountability, adherence to moralizing rules about alcohol and abstinence, to media coverage that individualized the scandal.

Conclusions

Looking at extraordinary events such as transplant scandals from an anthropological perspective offers an analysis that goes beyond the singular, scandalous event. An anthropological analysis allows to highlight the ordinary and ambivalent ‘scandalous’ features of transplant medicine It examines transplant medicine at the intersection of biomedicine, politics, and morality.

2012年,德国的器官移植丑闻被国内和国际媒体曝光并报道。本文对这一丑闻进行了人类学分析,并通过对其非同寻常和普通特征的仔细观察来审视其“丑闻”特征。方法以民族志研究为基础,采用参与观察、访谈、媒体和文献分析等多种方法。结果德国的移植丑闻揭示了国家移植系统的系统性“丑闻”特征。从决策严重缺乏透明度,问责的法律框架薄弱,遵守关于酗酒和戒酒的道德规则,到媒体报道将丑闻个人化。从人类学的角度来看像移植丑闻这样的特殊事件,可以提供一种超越单一丑闻事件的分析。人类学分析可以突出移植医学的普通和矛盾的“丑闻”特征,它在生物医学,政治和道德的交叉点检查移植医学。
{"title":"A revealing scandal: The German transplant scandal between structural failures, moralizing rules, and ambivalent manipulations","authors":"Julia Rehsmann","doi":"10.1016/j.liver.2023.100168","DOIUrl":"https://doi.org/10.1016/j.liver.2023.100168","url":null,"abstract":"<div><h3>Introduction</h3><p>In 2012, the German transplant scandal was uncovered and reported in the national and international media. This article offers an anthropological analysis of the scandal and examines its ‘scandalous’ characteristics by taking a close look at its extraordinary and ordinary features.</p></div><div><h3>Methods</h3><p>The article is based on ethnographic research using multiple methods including participant observation, interviewing as well as media and document analysis.</p></div><div><h3>Results</h3><p>The transplant scandal in Germany revealed systemic ‘scandalous’ features of the national transplant system. From a significant lack of transparency in decision making, a weak legal framework for accountability, adherence to moralizing rules about alcohol and abstinence, to media coverage that individualized the scandal.</p></div><div><h3>Conclusions</h3><p>Looking at extraordinary events such as transplant scandals from an anthropological perspective offers an analysis that goes beyond the singular, scandalous event. An anthropological analysis allows to highlight the ordinary and ambivalent ‘scandalous’ features of transplant medicine It examines transplant medicine at the intersection of biomedicine, politics, and morality.</p></div>","PeriodicalId":100799,"journal":{"name":"Journal of Liver Transplantation","volume":"11 ","pages":"Article 100168"},"PeriodicalIF":0.0,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49881982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Understanding the patient perspective of weight management while on the liver transplant waitlist 了解患者的体重管理的角度,而在肝移植等待名单
Pub Date : 2023-08-01 DOI: 10.1016/j.liver.2023.100159
Ariana Chirban , Anushi Shah , Taylor M Coe , Heidi Yeh , Jennie Galpern , Jessica Witchey , Lorraine Castaldo , Nahel Elias , Angela Fitch , Leigh Anne Dageforde

Introduction

Obesity-associated comorbidities increase risks for patients undergoing liver transplant. In this study, we explore patient perspectives and motivation for healthy weight management among patients on the liver transplant waiting list.

Methods

This is a cross-sectional, observational, electronic survey-based study. A survey on weight management was administered to patients on the liver transplant waiting list. Demographic and clinical data were collected from patients’ medical records. Data was analyzed using Pearson's chi-squared, Fisher's exact, and Student's t-tests.

Results

Respondents had a mean age of 54.4 years, were predominately male (62.0%) with a mean BMI of 29.2 kg/m2 with alcoholic cirrhosis as the leading etiology of liver disease (33.9%). Among patients with a BMI≥30 kg/m2, 59.0% perceived that they were overweight and 23.1% believed they were underweight. Among patients with BMI≥30 kg/m2 who perceived they were overweight, 39.1% were actively trying to lose weight and 60.9% were trying to keep from gaining weight. Regardless of current weight, there was a median increase in BMI for patients who categorized themselves as having lost weight or maintained weight since being waitlisted.

Conclusion

Many patients with a BMI≥30 kg/m2 did not perceive themselves as overweight and were not actively trying to lose weight. Weight perception was not consistent with actual weight change while waitlisted for liver transplant. Further research is needed to understand how weight awareness and weight perception impacts motivation for weight loss.

肥胖相关的合并症增加了接受肝移植患者的风险。在这项研究中,我们在肝移植等待名单上的患者中探讨了患者的观点和健康体重管理的动机。方法这是一项基于横断面、观察性、电子调查的研究。对肝移植等待名单上的患者进行了一项关于体重管理的调查。从患者的医疗记录中收集人口统计学和临床数据。使用皮尔逊卡方检验、Fisher精确检验和Student t检验对数据进行分析。结果被调查者平均年龄54.4岁,主要为男性(62.0%),平均BMI为29.2kg/m2,酒精性肝硬化是肝病的主要病因(33.9%)。在BMI≥30kg/m2的患者中,59.0%的人认为自己超重,23.1%的人认为体重不足。在BMI≥30 kg/m2且认为自己超重的患者中,39.1%的患者积极尝试减肥,60.9%的患者试图避免体重增加。无论目前的体重如何,那些自被列入候补名单以来将自己归类为减肥或保持体重的患者的BMI中位数都有所增加。结论许多BMI≥30kg/m2的患者并不认为自己超重,也没有积极尝试减肥。在等待肝移植时,体重感知与实际体重变化不一致。需要进一步的研究来了解体重意识和体重感知如何影响减肥动机。
{"title":"Understanding the patient perspective of weight management while on the liver transplant waitlist","authors":"Ariana Chirban ,&nbsp;Anushi Shah ,&nbsp;Taylor M Coe ,&nbsp;Heidi Yeh ,&nbsp;Jennie Galpern ,&nbsp;Jessica Witchey ,&nbsp;Lorraine Castaldo ,&nbsp;Nahel Elias ,&nbsp;Angela Fitch ,&nbsp;Leigh Anne Dageforde","doi":"10.1016/j.liver.2023.100159","DOIUrl":"https://doi.org/10.1016/j.liver.2023.100159","url":null,"abstract":"<div><h3>Introduction</h3><p>Obesity-associated comorbidities increase risks for patients undergoing liver transplant. In this study, we explore patient perspectives and motivation for healthy weight management among patients on the liver transplant waiting list.</p></div><div><h3>Methods</h3><p>This is a cross-sectional, observational, electronic survey-based study. A survey on weight management was administered to patients on the liver transplant waiting list. Demographic and clinical data were collected from patients’ medical records. Data was analyzed using Pearson's chi-squared, Fisher's exact, and Student's t-tests.</p></div><div><h3>Results</h3><p>Respondents had a mean age of 54.4 years, were predominately male (62.0%) with a mean BMI of 29.2 kg/m<sup>2</sup> with alcoholic cirrhosis as the leading etiology of liver disease (33.9%). Among patients with a BMI≥30 kg/m<sup>2</sup>, 59.0% perceived that they were overweight and 23.1% believed they were underweight. Among patients with BMI≥30 kg/m<sup>2</sup> who perceived they were overweight, 39.1% were actively trying to lose weight and 60.9% were trying to keep from gaining weight. Regardless of current weight, there was a median increase in BMI for patients who categorized themselves as having lost weight or maintained weight since being waitlisted.</p></div><div><h3>Conclusion</h3><p>Many patients with a BMI≥30 kg/m<sup>2</sup> did not perceive themselves as overweight and were not actively trying to lose weight. Weight perception was not consistent with actual weight change while waitlisted for liver transplant. Further research is needed to understand how weight awareness and weight perception impacts motivation for weight loss.</p></div>","PeriodicalId":100799,"journal":{"name":"Journal of Liver Transplantation","volume":"11 ","pages":"Article 100159"},"PeriodicalIF":0.0,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49882498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hemodynamic monitoring in liver Transplantation patients in the third millennium 第三个千年肝移植患者血流动力学监测
Pub Date : 2023-08-01 DOI: 10.1016/j.liver.2023.100156
Giorgio Della Rocca , Alessandra Della Rocca

In patients undergoing orthotopic liver transplantation (OLTx) surgery, the intraoperative hemodynamic monitoring technique that is most utilized is still the pulmonary artery catheter (PAC). The popularity of transesophageal echocardiography (TEE) is increasing, so today's updated issue is the following: should the use of PAC and/or volumetric monitoring with transpulmonary thermodilution and/or advanced volumetric PAC be limited in clinical practice, only for some high risk patients? Could we use the TEE, if necessary, in less critical ill patients undergoing OLTx surgery?

We can integrate all of the aforementioned monitoring techniques in an increasing modular step wise monitoring concept. But in an uncertain hemodynamic situation, transthoracic and/or transoesophageal echocardiographic evaluation represents a cornerstone.

The use of echocardiography during OLTx is more and more common with several benefits demonstrated particularly by the TEE in this patient population.

To achieve and maintain adequate tissue perfusion becomes difficult in case of major bleeding, an event quite possible to occur during OLTx, affecting the immediate and the late outcome.

All the clinicians agree that bleeding interfere with the choice of hemodynamic monitoring and or vice versa.

A reasonable compromise is to find a balance between the need to extend monitoring in high-risk surgical patients and the average consumption of blood products that characterizes each individual transplant center. This is also in line with what is shown in literature in terms of Maximum Surgical Blood Ordering Schedule (MSBOS).

在接受原位肝移植(OLTx)手术的患者中,最常用的术中血液动力学监测技术仍然是肺动脉导管(PAC)。经食道超声心动图(TEE)越来越受欢迎,因此今天的最新问题是:在临床实践中,是否应该限制PAC和/或容量监测与经肺热稀释和/或高级容量PAC的使用,仅针对一些高危患者?如果有必要,我们可以在接受OLTx手术的病情较轻的患者中使用TEE吗?我们可以将上述所有监控技术集成到一个日益模块化的逐步监控概念中。但在血液动力学不确定的情况下,经胸和/或经食管超声心动图评估是一个基石。超声心动图在OLTx中的应用越来越普遍,TEE在该患者群体中表现出了一些益处。在大出血的情况下,要实现和保持足够的组织灌注变得困难,这一事件很可能在OLTx期间发生,影响即时和晚期结果。所有临床医生都认为出血会干扰血液动力学监测的选择,反之亦然。一个合理的折衷方案是在扩大高危手术患者监测的需要和每个移植中心的血液制品平均消耗量之间找到平衡。这也符合文献中关于最大手术血液订购时间表(MSBOS)的内容。
{"title":"Hemodynamic monitoring in liver Transplantation patients in the third millennium","authors":"Giorgio Della Rocca ,&nbsp;Alessandra Della Rocca","doi":"10.1016/j.liver.2023.100156","DOIUrl":"https://doi.org/10.1016/j.liver.2023.100156","url":null,"abstract":"<div><p>In patients undergoing orthotopic liver transplantation (OLTx) surgery, the intraoperative hemodynamic monitoring technique that is most utilized is still the pulmonary artery catheter (PAC). The popularity of transesophageal echocardiography (TEE) is increasing, so today's updated issue is the following: should the use of PAC and/or volumetric monitoring with transpulmonary thermodilution and/or advanced volumetric PAC be limited in clinical practice, only for some high risk patients? Could we use the TEE, if necessary, in less critical ill patients undergoing OLTx surgery?</p><p>We can integrate all of the aforementioned monitoring techniques in an increasing modular step wise monitoring concept. But in an uncertain hemodynamic situation, transthoracic and/or transoesophageal echocardiographic evaluation represents a cornerstone.</p><p>The use of echocardiography during OLTx is more and more common with several benefits demonstrated particularly by the TEE in this patient population.</p><p>To achieve and maintain adequate tissue perfusion becomes difficult in case of major bleeding, an event quite possible to occur during OLTx, affecting the immediate and the late outcome.</p><p>All the clinicians agree that bleeding interfere with the choice of hemodynamic monitoring and or vice versa.</p><p>A reasonable compromise is to find a balance between the need to extend monitoring in high-risk surgical patients and the average consumption of blood products that characterizes each individual transplant center. This is also in line with what is shown in literature in terms of Maximum Surgical Blood Ordering Schedule (MSBOS).</p></div>","PeriodicalId":100799,"journal":{"name":"Journal of Liver Transplantation","volume":"11 ","pages":"Article 100156"},"PeriodicalIF":0.0,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49882503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Perioperative management of severe portopulmonary hypertension in a paediatric living donor liver transplantation using pulmonary vasodilators 应用肺血管扩张剂治疗小儿活体肝移植中严重门脉性肺动脉高压的围手术期治疗
Pub Date : 2023-08-01 DOI: 10.1016/j.liver.2023.100158
Annu Sarin Jolly, Vidyadhar Metri, Sanjay K. Goja, Nandini Dave, Ashok Thorat, Vaibhav, Manoj Singh

Portopulmonary hypertension (PoPH) is a rare but serious disorder carrying a very poor prognosis. PoPH is defined as the presence of pulmonary arterial hypertension (PAH) associated with portal hypertension, with or without underlying liver disease. We are reporting our institutional experience of anaesthetic management of an 8-year old female child weighing 20 kg with severe PoPH who underwent liver transplantation (LT). The use of pulmonary vasodilators in the perioperative period along with a carefully planned anaesthetic strategy was critical in the successful outcome of this potentially lethal disorder.

门脉性肺动脉高压(PoPH)是一种罕见但严重的疾病,预后很差。PoPH被定义为肺动脉高压(PAH)伴有门脉高压,伴有或不伴有潜在的肝脏疾病。我们报告我们的机构经验麻醉管理的8岁女童体重20公斤,严重PoPH谁接受肝移植(LT)。围手术期使用肺血管扩张剂以及精心规划的麻醉策略是成功治疗这种潜在致命疾病的关键。
{"title":"Perioperative management of severe portopulmonary hypertension in a paediatric living donor liver transplantation using pulmonary vasodilators","authors":"Annu Sarin Jolly,&nbsp;Vidyadhar Metri,&nbsp;Sanjay K. Goja,&nbsp;Nandini Dave,&nbsp;Ashok Thorat,&nbsp;Vaibhav,&nbsp;Manoj Singh","doi":"10.1016/j.liver.2023.100158","DOIUrl":"https://doi.org/10.1016/j.liver.2023.100158","url":null,"abstract":"<div><p>Portopulmonary hypertension (PoPH) is a rare but serious disorder carrying a very poor prognosis. PoPH is defined as the presence of pulmonary arterial hypertension (PAH) associated with portal hypertension, with or without underlying liver disease. We are reporting our institutional experience of anaesthetic management of an 8-year old female child weighing 20 kg with severe PoPH who underwent liver transplantation (LT). The use of pulmonary vasodilators in the perioperative period along with a carefully planned anaesthetic strategy was critical in the successful outcome of this potentially lethal disorder.</p></div>","PeriodicalId":100799,"journal":{"name":"Journal of Liver Transplantation","volume":"11 ","pages":"Article 100158"},"PeriodicalIF":0.0,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49882548","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic value of two-dimensional strain-echocardiography in patients with liver cirrhosis in Intensive care Unit. A prospective, observational Study 二维应变超声心动图对重症监护病房肝硬化患者的预后价值。一项前瞻性观察性研究
Pub Date : 2023-08-01 DOI: 10.1016/j.liver.2023.100165
Sophia EL Boukili, Laurent Reydellet, Valery Blasco, Karim Harti, Jacques Albanese, Cyril Nafati

Purpose

Cirrhotic cardiomyopathy (CCM) is a major comorbidity of cirrhosis. The diagnostic performance of conventional echocardiography is poor. Two-dimensional-strain echo-cardiography (2D-strain) detects myocardial dysfunction earlier than conventional echocardiography, with a significant prognostic value. The aim of our study is to assess whether the 2D-strain will allow a more relevant assessment of CCM in cirrhotic patients than conventional echocardiography. The secondary objective is to determine if altered strain or strain rate are associated with cirrhotic patient's outcome in intensive care unit (ICU).

Methods

Conventional echocardiography and 2D-strain were performed on 44 consecutive patients within 24 hours of admission to the ICU. Using 2D-strain, the global-longitudinal-strain (GLS) was assessed.

Results

GLS was impaired in 64% of patients. GLS was significantly higher in the patients who died compared with those who survived, using 28-day mortality rate (-17 vs -14 p < 0.039). Regarding conventional echocardiography, no factor was associated with increased mortality.

Conclusion

GLS is correlated to cirrhotic patient's prognosis in intensive care, while conventional echocardiography shows no dysfunction.

目的肝硬化性心肌病(CCM)是肝硬化的主要合并症。常规超声心动图的诊断性能较差。二维应变超声心动图(2D-strain)比常规超声心动图更早发现心肌功能障碍,具有重要的预后价值。我们研究的目的是评估2D-strain是否能够比传统超声心动图更相关地评估肝硬化患者的CCM。次要目的是确定应变或应变率的改变是否与肝硬化患者在重症监护病房(ICU)的预后有关。方法对44例连续入院24小时的患者行常规超声心动图和二维应变检查。采用2d -应变法对全局-纵向-应变(GLS)进行评估。结果64%的患者gls功能受损。使用28天死亡率计算,死亡患者的GLS明显高于存活患者(-17 vs -14 p <0.039)。对于常规超声心动图,没有任何因素与死亡率增加相关。结论ls与肝硬化重症监护患者预后相关,而常规超声心动图显示无功能障碍。
{"title":"Prognostic value of two-dimensional strain-echocardiography in patients with liver cirrhosis in Intensive care Unit. A prospective, observational Study","authors":"Sophia EL Boukili,&nbsp;Laurent Reydellet,&nbsp;Valery Blasco,&nbsp;Karim Harti,&nbsp;Jacques Albanese,&nbsp;Cyril Nafati","doi":"10.1016/j.liver.2023.100165","DOIUrl":"https://doi.org/10.1016/j.liver.2023.100165","url":null,"abstract":"<div><h3>Purpose</h3><p>Cirrhotic cardiomyopathy (CCM) is a major comorbidity of cirrhosis. The diagnostic performance of conventional echocardiography is poor. Two-dimensional-strain echo-cardiography (2D-strain) detects myocardial dysfunction earlier than conventional echocardiography, with a significant prognostic value. The aim of our study is to assess whether the 2D-strain will allow a more relevant assessment of CCM in cirrhotic patients than conventional echocardiography. The secondary objective is to determine if altered strain or strain rate are associated with cirrhotic patient's outcome in intensive care unit (ICU).</p></div><div><h3>Methods</h3><p>Conventional echocardiography and 2D-strain were performed on 44 consecutive patients within 24 hours of admission to the ICU. Using 2D-strain, the global-longitudinal-strain (GLS) was assessed.</p></div><div><h3>Results</h3><p>GLS was impaired in 64% of patients. GLS was significantly higher in the patients who died compared with those who survived, using 28-day mortality rate (-17 vs -14 <em>p &lt;</em> 0.039). Regarding conventional echocardiography, no factor was associated with increased mortality.</p></div><div><h3>Conclusion</h3><p>GLS is correlated to cirrhotic patient's prognosis in intensive care, while conventional echocardiography shows no dysfunction.</p></div>","PeriodicalId":100799,"journal":{"name":"Journal of Liver Transplantation","volume":"11 ","pages":"Article 100165"},"PeriodicalIF":0.0,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49881979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impacts of in situ donor partial hepatectomy in pediatric liver transplantation 原位供肝部分切除术对儿童肝移植的影响
Pub Date : 2023-08-01 DOI: 10.1016/j.liver.2023.100157
Z. Tremblay , A. Kawaguchi , A. Calderone , M. Beaunoyer , F. Alvarez , M. Lallier , P. Jouvet

Background

Pediatric liver transplantation is performed with either whole, reduced, split livers depending on the technical aspects of the surgery and the discrepancy between donor and recipient body dimensions. The optimal method of partial hepatectomy for pediatric transplants remains debated to this day: either in situ (i.e. occurring before liver removal from the donor) or ex situ (i.e. taking place after liver removal). In 2007, our tertiary academic center changed its surgical protocol from ex situ to in situ partial hepatectomy in deceased donor mainly to decrease bleeding complication risk among other amendments. Our study aimed to evaluate the clinical impact of this major modification on the post-operative blood products volume transfusion.

Methods

A retrospective analysis of 104 patients who underwent liver transplantation at our pediatric center between 1998 and 2016 was performed. Patients receiving multiple organ transplantations or re-transplantation were excluded from the study. Differences in blood products transfusion volume, post-operative complications and mortality rates were compared between two periods implementing different surgical transplantation protocols: ex situ partial hepatectomy from 1998 to 2006 and in situ partial hepatectomy from 2007 to 2016.

Results

42 children from the original ex situ protocol group and 62 children from the modified in situ protocol group were included in the study. The median age and weight were 1.5 years (0.7–4.8 kg) and 11.1 kg (7.9–18.2), respectively. There were no significant differences in demographic data between groups. A significant decrease in liver transplant cold ischemia time was observed in the in situ group compared to the ex situ group (p < 0.001). A significant increase in vasopressor use was observed for the in situ group (64% (IS) vs. 24% ex situ group (p < 0.001)), as part of the protocol modifications. Median perioperative blood products transfusion volume was not significantly different between both groups: 275 ml/kg (76–497) ex situ group vs. 229 ml/kg (76–499) in situ group (p = 0.82). We observed a 28-day and 90-day mortality rate of 14.3% and 16.6%, respectively, for the ex situ group and 6.5% and 8.1%, respectively, for the in situ group. Hepatic artery thrombosis was found in the first 7 days in 7% of the ex situ group patients and 6% of the in situ group patients. There were no significant differences in post-operative mortality and morbidity rates observed between groups (p value of 0.29 and 0.28 for 28-days and 90-days mortality rates, respectively).

Conclusions

Although the median amount of transfusion was higher in the ex-situ group, our stud

背景根据手术的技术方面以及供体和受体身体尺寸之间的差异,儿童肝移植可以用完整的、缩小的、分裂的肝脏进行。儿童肝部分切除术的最佳方法至今仍存在争议:原位(即在从供体肝脏切除之前进行)或离地(即在肝脏切除后进行)。2007年,我们的三级学术中心将其手术方案从离地肝部分切除改为原位肝部分切除,主要是为了降低出血并发症的风险。我们的研究旨在评估这一重大修改对术后血液制品容量输血的临床影响。方法对1998年至2016年间在我院儿科中心接受肝移植的104例患者进行回顾性分析。接受多器官移植或再次移植的患者被排除在研究之外。血液制品输注量的差异,比较了1998年至2006年肝部分切除术和2007年至2016年肝部分原位切除术两个实施不同手术方案的时期的术后并发症和死亡率。结果42名来自原始肝部分原位方案组的儿童和62名来自改良肝部分原位方案组的儿童被纳入研究。中位年龄和体重分别为1.5岁(0.7–4.8公斤)和11.1公斤(7.9–18.2公斤)。各组之间的人口统计数据没有显著差异。与非原位组相比,原位组观察到肝移植冷缺血时间显著减少(p<0.001)。作为方案修改的一部分,原位组的血管升压药使用显著增加(64%(IS)对24%非原位组(p<001))。两组围手术期血液制品输注量中位数无显著差异:275 ml/kg(76-497)非原位组与229 ml/kg(76.499)原位组(p=0.82)。我们观察到非原位组28天和90天的死亡率分别为14.3%和16.6%,原位组分别为6.5%和8.1%。在前7天,7%的非原位组患者和6%的原位组患者发现肝动脉血栓形成。两组之间的术后死亡率和发病率没有显著差异(28天和90天死亡率的p值分别为0.29和0.28),原位和非原位肝部分切除术的发病率和死亡率。应进行进一步的多中心研究以证实这些结果。证据级别III
{"title":"Impacts of in situ donor partial hepatectomy in pediatric liver transplantation","authors":"Z. Tremblay ,&nbsp;A. Kawaguchi ,&nbsp;A. Calderone ,&nbsp;M. Beaunoyer ,&nbsp;F. Alvarez ,&nbsp;M. Lallier ,&nbsp;P. Jouvet","doi":"10.1016/j.liver.2023.100157","DOIUrl":"https://doi.org/10.1016/j.liver.2023.100157","url":null,"abstract":"<div><h3>Background</h3><p>Pediatric liver transplantation is performed with either whole, reduced, split livers depending on the technical aspects of the surgery and the discrepancy between donor and recipient body dimensions. The optimal method of partial hepatectomy for pediatric transplants remains debated to this day: either <em>in situ</em> (<em>i.e.</em> occurring before liver removal from the donor) or <em>ex situ</em> (<em>i.e.</em> taking place after liver removal). In 2007, our tertiary academic center changed its surgical protocol from <em>ex situ</em> to <em>in situ</em> partial hepatectomy in deceased donor mainly to decrease bleeding complication risk among other amendments. Our study aimed to evaluate the clinical impact of this major modification on the post-operative blood products volume transfusion.</p></div><div><h3>Methods</h3><p>A retrospective analysis of 104 patients who underwent liver transplantation at our pediatric center between 1998 and 2016 was performed. Patients receiving multiple organ transplantations or re-transplantation were excluded from the study. Differences in blood products transfusion volume, post-operative complications and mortality rates were compared between two periods implementing different surgical transplantation protocols: <em>ex situ</em> partial hepatectomy from 1998 to 2006 and <em>in situ</em> partial hepatectomy from 2007 to 2016.</p></div><div><h3>Results</h3><p>42 children from the original <em>ex situ</em> protocol group and 62 children from the modified <em>in situ</em> protocol group were included in the study. The median age and weight were 1.5 years (0.7–4.8 kg) and 11.1 kg (7.9–18.2), respectively. There were no significant differences in demographic data between groups. A significant decrease in liver transplant cold ischemia time was observed in the <em>in situ</em> group compared to the <em>ex situ</em> group (<em>p</em> &lt; 0.001). A significant increase in vasopressor use was observed for the <em>in situ</em> group (64% (IS) <em>vs</em>. 24% <em>ex situ</em> group (<em>p</em> &lt; 0.001)), as part of the protocol modifications. Median perioperative blood products transfusion volume was not significantly different between both groups: 275 ml/kg (76–497) <em>ex situ</em> group <em>vs</em>. 229 ml/kg (76–499) <em>in situ</em> group (<em>p</em> = 0.82). We observed a 28-day and 90-day mortality rate of 14.3% and 16.6%, respectively, for the <em>ex situ</em> group and 6.5% and 8.1%, respectively, for the <em>in situ</em> group. Hepatic artery thrombosis was found in the first 7 days in 7% of the <em>ex situ</em> group patients and 6% of the <em>in situ</em> group patients. There were no significant differences in post-operative mortality and morbidity rates observed between groups (p value of 0.29 and 0.28 for 28-days and 90-days mortality rates, respectively).</p></div><div><h3>Conclusions</h3><p>Although the median amount of transfusion was higher in the ex-situ group, our stud","PeriodicalId":100799,"journal":{"name":"Journal of Liver Transplantation","volume":"11 ","pages":"Article 100157"},"PeriodicalIF":0.0,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49882497","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Liver transplant registries: Need, benefits and risks 肝移植登记:需要、益处和风险
Pub Date : 2023-08-01 DOI: 10.1016/j.liver.2023.100160
James Neuberger
{"title":"Liver transplant registries: Need, benefits and risks","authors":"James Neuberger","doi":"10.1016/j.liver.2023.100160","DOIUrl":"https://doi.org/10.1016/j.liver.2023.100160","url":null,"abstract":"","PeriodicalId":100799,"journal":{"name":"Journal of Liver Transplantation","volume":"11 ","pages":"Article 100160"},"PeriodicalIF":0.0,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49882501","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of liver transplantation eligibility for ACLF patients ACLF患者肝移植适格性评估
Pub Date : 2023-08-01 DOI: 10.1016/j.liver.2023.100167
Julie Gaudefroy , Paul Brunet , Baptiste Lordier , Benjamin Lebas , Julien Pottecher

Acute on Chronic Liver Failure (ACLF) is a severe condition that can be seen in all patients with liver disease and is associated with high short-term mortality. Decompensated cirrhosis and organ failures resulting can lead to an admission in Intensive Care Unit (ICU) where only few tools can be used to evaluate the safety or futility of care, including liver transplantation. High short-term mortality for patients with ACLF admitted in ICU is a reason to ethically propose a liver transplantation as a curative treatment despite the existence of multi-organ failures. However, caution is advised for patients with grade-3 ACLF as they have to be attentively selected by a multidisciplinary approach, carefully evaluated and may benefit from an early transplant with a low-risk donor graft. Recent use of perfusion machine to increase outcomes after liver transplant in these urgent situations still needs to be evaluated. This review summarizes the ACLF entity and presents some recommendations about liver transplantation (LT) candidates in terms of selection, evaluation and timing of LT.

急性慢性肝功能衰竭(ACLF)是一种严重的疾病,可以在所有肝病患者中看到,并与高短期死亡率有关。失代偿性肝硬化和由此导致的器官衰竭可能导致入住重症监护室(ICU),在那里,只有很少的工具可以用来评估护理的安全性或无效性,包括肝移植。尽管存在多器官衰竭,但入住ICU的ACLF患者的短期死亡率很高,这是合乎道德地提出肝移植作为治疗方法的原因。然而,建议3级ACLF患者谨慎,因为他们必须通过多学科方法仔细选择,仔细评估,并可能从低风险供体移植物的早期移植中受益。在这些紧急情况下,最近使用灌注机来增加肝移植后的结果仍需评估。这篇综述总结了ACLF实体,并就肝移植(LT)的选择、评估和时机提出了一些建议。
{"title":"Assessment of liver transplantation eligibility for ACLF patients","authors":"Julie Gaudefroy ,&nbsp;Paul Brunet ,&nbsp;Baptiste Lordier ,&nbsp;Benjamin Lebas ,&nbsp;Julien Pottecher","doi":"10.1016/j.liver.2023.100167","DOIUrl":"https://doi.org/10.1016/j.liver.2023.100167","url":null,"abstract":"<div><p>Acute on Chronic Liver Failure (ACLF) is a severe condition that can be seen in all patients with liver disease and is associated with high short-term mortality. Decompensated cirrhosis and organ failures resulting can lead to an admission in Intensive Care Unit (ICU) where only few tools can be used to evaluate the safety or futility of care, including liver transplantation. High short-term mortality for patients with ACLF admitted in ICU is a reason to ethically propose a liver transplantation as a curative treatment despite the existence of multi-organ failures. However, caution is advised for patients with grade-3 ACLF as they have to be attentively selected by a multidisciplinary approach, carefully evaluated and may benefit from an early transplant with a low-risk donor graft. Recent use of perfusion machine to increase outcomes after liver transplant in these urgent situations still needs to be evaluated. This review summarizes the ACLF entity and presents some recommendations about liver transplantation (LT) candidates in terms of selection, evaluation and timing of LT.</p></div>","PeriodicalId":100799,"journal":{"name":"Journal of Liver Transplantation","volume":"11 ","pages":"Article 100167"},"PeriodicalIF":0.0,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49882504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment and management of patients with portopulmonary hypertension undergoing liver transplantation 肝移植术中门肺动脉高压患者的评估和处理
Pub Date : 2023-07-20 DOI: 10.1016/j.liver.2023.100169
Gabriel Wisenfeld Paine , Michael Toolan , Jeremy S Nayagam , Deepak Joshi , Brian J Hogan , Colm McCabe , Philip Marino , Sameer Patel

Portopulmonary hypertension (PoPH) is defined as the presence of otherwise unexplained pre-capillary pulmonary hypertension in patients with portal hypertension of cirrhotic or non-cirrhotic aetiology. PoPH occurs in at least 5–8.5% of patients being worked up for a liver transplant (LT) and its prevalence is thought to be increasing. Uncontrolled PoPH prior to LT is associated with high perioperative morbidity and mortality, with severe PoPH being considered a contraindication to LT. Early recognition and appropriate management of PoPH in patients being considered for LT is therefore imperative to achieve optimal outcomes. This review provides a detailed overview of: the epidemiology, prognosis and pathophysiology of PoPH; clinical assessment, screening and diagnostic approach; and pre-, peri‑ and post-transplant management of PoPH in patients undergoing LT. The current evidence base in this area is limited. This review particularly focuses on the evidence both supporting and challenging current practices and highlights areas for future research.

门静脉高压(PoPH)被定义为肝硬化或非肝硬化病因的门静脉高压患者存在其他无法解释的毛细血管前肺动脉高压。PoPH发生在至少5-8.5%的接受肝移植(LT)的患者中,其患病率被认为正在增加。LT前不受控制的PoPH与高围手术期发病率和死亡率相关,严重的PoPH被认为是LT的禁忌症。因此,在考虑LT的患者中尽早识别和适当管理PoPH对于实现最佳结果至关重要。这篇综述提供了一个详细的概述:PoPH的流行病学,预后和病理生理学;临床评估、筛查和诊断方法;以及LT患者移植前、移植前后PoPH的管理。目前这方面的证据基础有限。这篇综述特别关注支持和挑战当前实践的证据,并强调了未来研究的领域。
{"title":"Assessment and management of patients with portopulmonary hypertension undergoing liver transplantation","authors":"Gabriel Wisenfeld Paine ,&nbsp;Michael Toolan ,&nbsp;Jeremy S Nayagam ,&nbsp;Deepak Joshi ,&nbsp;Brian J Hogan ,&nbsp;Colm McCabe ,&nbsp;Philip Marino ,&nbsp;Sameer Patel","doi":"10.1016/j.liver.2023.100169","DOIUrl":"https://doi.org/10.1016/j.liver.2023.100169","url":null,"abstract":"<div><p>Portopulmonary hypertension (PoPH) is defined as the presence of otherwise unexplained pre-capillary pulmonary hypertension in patients with portal hypertension of cirrhotic or non-cirrhotic aetiology. PoPH occurs in at least 5–8.5% of patients being worked up for a liver transplant (LT) and its prevalence is thought to be increasing. Uncontrolled PoPH prior to LT is associated with high perioperative morbidity and mortality, with severe PoPH being considered a contraindication to LT. Early recognition and appropriate management of PoPH in patients being considered for LT is therefore imperative to achieve optimal outcomes. This review provides a detailed overview of: the epidemiology, prognosis and pathophysiology of PoPH; clinical assessment, screening and diagnostic approach; and pre-, peri‑ and post-transplant management of PoPH in patients undergoing LT. The current evidence base in this area is limited. This review particularly focuses on the evidence both supporting and challenging current practices and highlights areas for future research.</p></div>","PeriodicalId":100799,"journal":{"name":"Journal of Liver Transplantation","volume":"12 ","pages":"Article 100169"},"PeriodicalIF":0.0,"publicationDate":"2023-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50203521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiovascular assessment of candidates for liver transplant 肝移植候选者的心血管评估
Pub Date : 2023-05-01 DOI: 10.1016/j.liver.2023.100153
Manuel Lozano , Miguel Molina , Jesús Zarauza , Federico Castillo , Roberto Fernández-Santiago , Edward J. Anderson , Emilio Fábrega , Juan C. Rodríguez-Sanjuán

Cardiovascular events are the most important cause of morbidity and mortality after liver transplant (LT), since many recipients are older with cardiovascular risk factors and pathophysiology particular to end stage liver disease. Moreover, the LT procedure is associated with a unique cardiac risk. Detection of cardiovascular disease and stratification of risk have, therefore, an important impact on the prognosis of these patients.

心血管事件是肝移植(LT)后发病和死亡的最重要原因,因为许多接受者年龄较大,有心血管危险因素和终末期肝病的病理生理特征。此外,肝移植手术具有独特的心脏风险。因此,心血管疾病的检测和风险分层对这些患者的预后有重要影响。
{"title":"Cardiovascular assessment of candidates for liver transplant","authors":"Manuel Lozano ,&nbsp;Miguel Molina ,&nbsp;Jesús Zarauza ,&nbsp;Federico Castillo ,&nbsp;Roberto Fernández-Santiago ,&nbsp;Edward J. Anderson ,&nbsp;Emilio Fábrega ,&nbsp;Juan C. Rodríguez-Sanjuán","doi":"10.1016/j.liver.2023.100153","DOIUrl":"https://doi.org/10.1016/j.liver.2023.100153","url":null,"abstract":"<div><p>Cardiovascular events are the most important cause of morbidity and mortality after liver transplant (LT), since many recipients are older with cardiovascular risk factors and pathophysiology particular to end stage liver disease. Moreover, the LT procedure is associated with a unique cardiac risk. Detection of cardiovascular disease and stratification of risk have, therefore, an important impact on the prognosis of these patients.</p></div>","PeriodicalId":100799,"journal":{"name":"Journal of Liver Transplantation","volume":"10 ","pages":"Article 100153"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49880130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Liver Transplantation
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1